Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 6.252M
March 31, 2026 15.20M
December 31, 2025 43.86M
September 30, 2025 17.67M
June 30, 2025 4.037M
March 31, 2025 2.094M
December 31, 2024 -22.20M
September 30, 2024 4.273M
June 30, 2024 0.114M
March 31, 2024 7.426M
December 31, 2023 3.84M
September 30, 2023 -8.568M
June 30, 2023 -7.77M
March 31, 2023 -7.476M
December 31, 2022 1.705M
September 30, 2022 3.927M
June 30, 2022 2.261M
March 31, 2022 2.841M
December 31, 2021 5.082M
September 30, 2021 6.006M
June 30, 2021 10.75M
March 31, 2021 2.658M
December 31, 2020 -1.10M
September 30, 2020 1.118M
June 30, 2020 -1.619M
Date Value
March 31, 2020 1.876M
December 31, 2019 0.95M
September 30, 2019 -0.738M
June 30, 2019 -0.345M
March 31, 2019 0.176M
December 31, 2018 0.687M
September 30, 2018 0.429M
June 30, 2018 -2.118M
March 31, 2018 -5.788M
December 31, 2017 -8.803M
September 30, 2017 -10.75M
June 30, 2017 -12.43M
March 31, 2017 -12.89M
December 31, 2016 -11.22M
September 30, 2016 -12.28M
June 30, 2016 -10.76M
March 31, 2016 -11.17M
December 31, 2015 -11.14M
September 30, 2015 -9.893M
June 30, 2015 -9.294M
March 31, 2015 -7.654M
December 31, 2014 -7.055M
September 30, 2014 -6.243M
June 30, 2014 -5.585M
March 31, 2014 -5.058M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Viatris, Inc. 2.331B
Zevra Therapeutics, Inc. 33.40M
Indivior Pharmaceuticals, Inc. -48.64M
Liquidia Corp. 167.71M
60 Degrees Pharmaceuticals, Inc. -8.775M